Effects of Yifukang Oral Liquid on Chemotherapy- and Radiotherapy-Induced Toxic and Side Effects of Myelosuppression, Leucopenia and Gastrointestinal Tract Disturbances|
Tian, Xi-Kui; Lv, Hong-Di; Zhao, Qing-Hua; Hao, Shao-Jun; Geng, Xiu-Li; Wang, Xi- Dong; Zhang, Zheng-Chen & Zhao, Jian-Chang
Purpose: To investigate the effects of Yifukang oral liquid (YFKOL) on chemotherapy- and
radiotherapy-induced myelosuppression, leucopenia and gastrointestinal tract disturbances.
Methods: The effects of YFKOL on myelosuppression, leucopenia and gastrointestinal tract
disturbances were assessed by cyclophosphamide- and Co60-induced leucopenia in mice, copper
sulfate-induced emesis in pigeons, ethanol-induced gastric mucosal lesions in rats, gastric emptying
and intestinal propulsion in mice.
Results: In cyclophosphamide- and Co60-induced leucopenia assays, the mean white blood cell count
(82.6 and 90.1 × 109/L; 7.3 and 8.2 × 109/L, respectively) and thighbone marrow granulocytes (66.1 %
and 67.4 %; 60.8 and 66.5 %, respectively) were significantly (p < 0.05) increased after treatment with
YFKOL (15 and 30 mL/kg), compared with the respective control (68.2 and 4.7 × 109/L; 58.2 and 53.1
%). In emesis, gastric mucosal lesions, gastric emptying and intestinal propulsion assays, the mean
frequency of emesis (30.8 and 22.3 times, respectively) and ulcer index (39.6 and 26.5, respectively)
significantly (p < 0.05) decreased, and the mean gastric emptying (25.0 and 24.0 %) and intestinal
propulsion (81.9 and 82.8 %) were significantly (p < 0.05) promoted after treatment with YFKOL (10 and
20 mL/kg), compared with the respective control (54.7 times, 62.8, 42.0 and 68.9 %).
Conclusion: YFKOL may suppress chemotherapy- and radiotherapy-induced myelosuppression,
leucopenia and gastrointestinal tract disturbances.
Yifukang oral liquid; Gastrointestinal tract disturbances; Leucopenia; Myelosuppression; Tumor; Chemotherapy; Radiotherapy